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ABSTRACT
Background and Objectives: Associations between blood lipids and risk of ischemic heart 
disease (IHD) have been reported in observational studies. However, due to confounding 
and reverse causation, observational studies are influenced by bias, thus their results show 
inconsistency in the effects of lipid levels on IHD. In this study, we evaluate whether lipid 
levels have an effect on the risk of IHD in a Korean population.
Methods: A 2-sample Mendelian randomization (MR) study, using the genetic variants 
associated with lipid levels as the instrumental variables was performed. Genetic variants 
significantly associated with lipid concentrations were obtained from the Korean Genome and 
Epidemiology Study (n=35,000), and the same variants on IHD were obtained from the Korean 
Cancer Prevention Study-II (n=13,855). Inverse variance weighting (IVW), weighted median, 
and MR-Egger approaches were used to assess the causal association between lipid levels and 
IHD. Radial MR methods were applied to remove outliers subject to pleiotropic bias.
Results: Causal association between low-density lipoprotein-cholesterol (LDL-C) and IHD 
was observed in the IVW method (odds ratio, 1.013; 95% confidence interval, 1.007–1.109). 
However, high-density lipoprotein-cholesterol (HDL-C) and triglyceride (TG) did not show 
causal association with IHD. In the Radial MR analysis of the relationship between HDL-C, 
TG and IHD, outliers were detected. Interestingly, after removing the outliers, a causal 
association between TG and IHD was found.
Conclusions: High levels LDL-C and TG were causally associated with increased IHD risk in 
a Korean population, these results are potentially useful as evidence of a significant causal 
relationship.
Keywords: Mendelian randomization analysis; Lipid; Ischemic heart disease
INTRODUCTION
Serum lipid levels play a significant role in the development of atherosclerotic cardiovascular 
diseases.1) When there is an increased concentration of low-density lipoprotein-cholesterol 
(LDL-C) or a decreased level of high-density lipoprotein-cholesterol (HDL-C), there is a 
progressive development of atherosclerotic plaque, which can cause cardiovascular disease.2)3)
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In observational epidemiological studies, increased LDL-C levels and increased triglyceride 
levels and decreased HDL-C levels are associated with an increased risk for coronary artery 
disease (CAD).4) However, it may be difficult to disentangle causation from association, 
especially in the presence of confounding and reverse causation.5) Effect estimates from 
observational studies may be prone to measurement error or biases, which can lead to the 
attenuation of estimates.
Mendelian randomization (MR) provides an alternative way of dealing with the limitations 
of observational studies. Recent MR studies on lipid level biomarkers showed that elevated 
LDL-C and triglyceride (TG) are causal risk factors for coronary heart disease (CHD).6) Unlike 
previous observational studies, genetically raised HDL-C levels might not be protective against 
myocardial infarction.7)8) The available evidence for the causal relevance of lipid biomarker 
from randomized trials or MR studies is inconsistent. In addition, although multivariable MR 
analyses has suggested a causal effect of increased TG on CAD risk,9) it is still controversial 
whether elevated serum TG levels is a risk factor for ischemic heart disease (IHD).10-12)
Therefore, in this study, we examined whether lipid levels are causally related to IHD risk 
using a 2-sample MR approach with a Korean population.13)
METHODS
Two-sample Mendelian randomization analysis
MR analyses is a method commonly used in epidemiology to estimates the causal 
relationship between exposure and disease based on natural experiments assigned to high 
and low levels of exposure depending on individual genetic variation. To investigate the 
causal relationship between lipid concentrations and IHD, we performed 2-sample inverse 
variance weighted (IVW) MR analyses using the Korean genome wide association study 
(GWAS)'s results data from their Korean Genome and Epidemiology Study (KoGES) as well 
as the results data from the Korean Cancer Prevention Study-II (KCPS-II) Biobank.
The exposure variables of interest were the genetic variants that are associated with 3 serum 
lipid fraction in the Korean population. From KoGES, genetic information related to lipid 
levels was obtained. The KoGES study included 223,000 people and collected data between 
2004 and 2013. The Korean chip project was genome-based chronic disease project that 
collected information on 830,000 specific genetic variations in the Korean population. 
Among the KoGES population, 35,000 participants who took part in the Korean-chip data 
study were recruited. After quality control excluded some participants (Hardy-Weinberg 
equilibrium<10−4, minor allele frequency<1%), a total of 33,598 subjects were selected for 
further analysis using the K-chip (http://nih.go.kr/menu.es?mid=a50303010100). Before 
conducting GWAS analyses, we performed imputation analysis using the 1000 Genome 
(1000G) Phase 3 dataset of East Asian populations (Japanese in Tokyo and Chinese in Beijing) 
as a reference panel.14) Then, linear regression with adjustment for age and sex was performed 
to identify the associations of genetic variants with serum lipid level. Statistical analysis 
was carried out using PLINK version 1.07 (http://zzz.bwh.harvard.edu/plink/). Based on 
genome-wide significance (p>10−8), we found 2,029 single nucleotide polymorphisms (SNPs) 
associated with HDL-C, 1,207 SNPs with LDL-C, and 3,757 SNPs with TG. Then, a clumping 
test (https://mrcieu.github.io/TwoSampleMR), which estimates the linkage disequilibrium 
between the SNPs selected using 1000G data, was performed to select instrumental 
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variables. Finally, 29, 20, and 20 independent SNPs of HDL-C, LDL-C, and TG (r2>0.001) 
were chosen as the instrumental variables.
The outcome of interest was IHD when looking at the KCPS-II Biobank. The number of 
participants in the cohort was 156,701 (94,840 men and 61,861 women), all these received 
medical examinations at one of 18 health promotion centers in Seoul and Gyeonggi-do 
Province between 2004 and 2013. The published Biobank profile papers provide detailed 
information.15) We define the IHD events we are interested in as the first nonfatal occurrence 
of IHD. We identified these events from insurance claims submitted to the National Health 
Insurance System (NHIS) which is the single provider of universal healthcare coverage in 
Korea. We ascertained nonfatal IHD events according to the International Classification 
of Diseases 10th revision (I20–I25) from the health insurance claims data of the NHIS. We 
conducted a validation study in collaboration with the NHIS. Participants provided written 
permission for the use of their personal information to give our study 673 IHD events 
between 1994 and 2007, each case was confirmed with individual hospital medical records 
and 73% of the myocardial infarction cases were validated.16)
Genotyping for outcome was carried out with K-chip (http://nih.go.kr/menu.
es?mid=a50303010100). The quality control procedure for SNPs was carried out using the 
same procedure as selection for the aforementioned test. GWAS analyses were conducted 
using the PLINK 1.07 program (http://zzz.bwh.harvard.edu/plink/).
Assumption of 2-sample Mendelian randomization
Two-sample MR analyses were performed to investigate the existence of a causal relationship 
between lipid levels and IHD.
MR necessitates that genetic instruments are related with a modifiable exposure of interest 
(assumption 1), and any relationship between the instruments and outcome is mediated by the 
exposure (assumption 2). The instrumental variable only affects the outcome through its effect on 
risk factors (assumption 3).17) An SNP that violates these assumptions is referred to as an invalid 
instrumental variable and its consideration in MR analyses may bias the results. In the absence of 
reliable information on the ratio and direction of functional pathways and multifaceted genetic 
variants, the consistency of the estimated direction of the effect was checked using additional MR 
methods, including MR-Egger weighted medians.18) The MR-Egger method provides a less biased 
effect estimate by assuming significant heterogeneity of directional pleiotropy and measurement 
error, this is unlike the IVW method which does not assume the intercept term of the model.19) 
The results are related and require a larger sample size for the same basal variance in exposure. 
The IVW and MR-Egger methods further assume that the pleiotropic effects of genetic variants 
are independent of the assumption of direct effect, and independent of the association with 
exposure known as instrument strength. In the case of violation, the weighted median method 
can provide consistent effect estimates even when up to 50% of the genetic variants do not fit into 
instrumental strengths that depend on the assumption of direct effect.
Sensitivity analyses
The MR-Radial method was used to identify heterogeneity (p value=0.05/number of SNPs). 
The directional pleiotropy method occurs when the net effect of the horizontal pleiotropy 
method over all SNPs is not zero, which would introduce bias into the IVW method 
estimation. When heterogeneity was detected, we removed outliers and repeated both the 
analysis and the IVW radial regression.
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We used the TwoSampleMR package20) and the RadialMR package21) to perform IVW, MR-
Egger regression, and weighted median analyses in R (version 3.4.3; R Foundation, Vienna, 
Austria) We ran the analysis using code provided at https://mrcieu.github.io/TwoSampleMR/ 
and https://github.com/WSpiller/RadialMR/.
Ethics statement
The Severance Medical Ethics Committee approved this study (No. 4-2011-0277).
RESULTS
Causal effect of lipids on ischemic heart disease
We screened out 69 lipid-specific instrumental variables (29 for HDL-C, 20 for LDL-C and 20 
for TG) when evaluating their associations with IHD (Supplementary Tables 1-3 and Figure 1).  
The Cochran's Q test showed that there is little evidence of instrumental heterogeneity for 
LDL-C (p value=0.378) or TG (p value=0.242). However, instrumental heterogeneity was 
observed for HDL-C at the marginal significance level of 0.05 (p value=0.032) (Figure 2). 
Motivated by this, we employed the IVW method for LDL-C and TG, and applied the MR-
Egger method for HDL-C when estimating their causal effects on IHD. Among the 3 lipids, 
we identified that only LDL-C was associated with IHD (Table 1). Specifically, the estimated 
odds ratio (OR) per 1 mg/dL increase of LDL-C on IHD was 1.013 (95% confidence interval 
[CI], 1.007–1.019; p value=9.44E-06) and was statistically significant. The OR per 1 mg/dL 
increase of HDL-C and TG for IHD was 0.995 (95% CI, 0.98–1.01; p value=0.552) and 1.002 
(95% CI, 0.999–1.004; p value=0.065) (Table 1), respectively. In the case of LDL-C, MR-
Egger regression analysis showed the presence of pleiotropy (p value=0.008). However, the 
possibility of pleiotropy was not found to be significant in further intercept analysis.
Sensitivity analyses to validate estimated causal effects
We subsequently performed sensitivity analyses to validate the causal association observed 
above. Using the weighted median method, the estimated OR per 1 mg/dL increase of HDL-C 
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Figure 1. Scatter plots to visualize causal effect of lipid levels on IHD risk. (A) HDL-C; (B) LDL-C; (C) TG. 
SNP = single nucleotide polymorphism; IHD = ischemic heart disease; HDL-C = high-density lipoprotein-cholesterol; LDL-C = low-density lipoprotein-cholesterol; 
TG = triglyceride; MR = Mendelian randomization; IVW = inverse variance weighting.
and TG on IHD was 1.001 (95% CI, 0.982–1.02; p value=0.879) and 1.002 (95% CI, 0.999–
1.004; p value=0.085); the LDL-C has a significant association (OR, 1.011; 95% CI, 1.003–1.02, 
p value=2.30E-03) (Table 1). However, the IVW Radial MR results delineated that the 2 
instrumental variables of HDL-C and TG that carry large effect sizes on IHD could potentially 
be outliers (i.e., HDL-C on rs2876971 in gene UBE2L3 and rs769446 in gene APOE; TG on 
rs438811 in gene APOC1 and rs9436224 in gene DOCK7) (Figure 2). Outliers did not exert any 
substantial influence on the estimated causal effect of HDL-C on IHD. However, after removal, 
the estimate of TG's effect on IHD was 0.002 (standard error=0.001, p value=0.006) (Table 2).
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Figure 2. Radial plots of SNP-IHD associations (beta*sqrt(Wj)) versus SNP-lipid level associations (sqrt(Wj)), with the IVW slope shown as a solid sky-blue line. 
Outliers are highlighted in orange. (A) HDL-C; (B) LDL-C; (C) TG. 
IVW = inverse variance weighting; SNP = single nucleotide polymorphism; IHD = ischemic heart disease; HDL-C = high-density lipoprotein-cholesterol; LDL-C = 
low-density lipoprotein-cholesterol; TG = triglyceride.
Table 1. Mendelian randomization for the effects of lipid levels on ischemic heart disease risk
Variables Method OR (95% CI) p value Number of SNPs
HDL-C Inverse variance weighted 0.995 (0.98–1.010) 0.552 29
Weighted median 1.001 (0.982–1.020) 0.879 29
MR-Egger regression 1.007 (0.980–1.034) 0.667 29
LDL-C Inverse variance weighted 1.013 (1.007–1.019) 9.44E-6 20
Weighted median 1.011 (1.003–1.020) 2.30E-3 20
MR-Egger regression 1.014 (1.005–1.024) 7.99E-3 20
TG Inverse variance weighted 1.002 (0.999–1.004) 0.065 20
Weighted median 1.002 (0.999–1.004) 0.085 20
MR-Egger regression 1.002 (0.997–1.006) 0.329 20
OR = odds ratio; CI = confidence interval; SNP = single nucleotide polymorphism; HDL-C = high-density lipoprotein-cholesterol; LDL-C = low-density lipoprotein-
cholesterol; TG = triglyceride; MR = Mendelian randomization.
Table 2. Inverse weighted variance radial regression results for lipid levels on ischemic heart disease risk
Variables Method Beta (SE) p value Number of SNPs*
HDL-C Inverse variance weighted −0.004 (0.007) 0.533 27
TG Inverse variance weighted 0.002 (0.001) 0.006 18
SE = standard error; SNP = single nucleotide polymorphism; HDL-C = high-density lipoprotein-cholesterol; TG = 
triglyceride.
*After removing outliers, remaining SNPs were analyzed.
DISCUSSION
This study assessed the causal relationship of LDL-C, HDL-C and TG on IHD using a 2-sample 
MR method. All these lipids are traditionally well known as risk factors for IHD. The 2-sample 
used for the MR approach included KoGES for exposure data and KCPS-II for outcome data.
The MR results showed that LDL-C and TG were causally related to IHD, but HDL-C was not 
causally related to IHD, which is consistent with results of previous studies.
Recent MR studies of IHD biomarkers show that LDL-C has a causal relationship with IHD, 
while the causality of association between HDL-C and IHD is not clear.10-12) These previous 
results are consistent with the results of this study. In the case of TG, however, it is still 
controversial whether elevated serum TG levels are a risk factor for IHD.10) In our study, 
the relationship between TG and IHD was heterogeneous. In other words, the 2 SNPs were 
determined to be outliers in the radial plot. The outliers associated with TG in this study were 
rs438811 in gene APOC1 and rs9436224 in gene DOCK7. The IVW method results analyzed with 
these 2 outliers showed no significant association with an OR,1.002 and a p value=0.065. 
However, after removing the 2 outliers using IVW radial regression, results showed a 
significant causal association with an OR,1.002 and a p value=0.006.
This study demonstrates the potential of TG as a causal factor for IHD. In a recent study, it 
was found that treatments that lower LDL-C or TG levels should lead to reductions in CHD 
risk proportional to their reduction in ApoB.22) However, cardiovascular outcome studies with 
TG-lowering agents still produce inconsistent results, meaning that there is no convincing 
evidence available that suggests lowering TG by any approach can reduce mortality.23) 
Therefore, causality studies for TG and IHD should be repeated in the future.
The evidence that LDL-C and TG are causally related to IHD is based on genetically 
determined LDL-C and TG. Genetically determined LDL-C and TG are characterized by being 
free of confounding variables, this problem has always affected the ability of observational 
studies to uncover true relevance. This does not mean that only genetically increased 
LDL-C and TG are the cause of IHD. This means that only genetic factors are used in the 
methodology for causality, and so not only the genetic increases LDL-C or TG but also the 
increases due to other life style risk factors can cause IHD.
There are several health implications for biomarkers' causality in certain diseases. First, 
causal biomarkers can reduce the incidence of related diseases if biomarkers can be reduced 
through drug or non-drug therapies. Second, causal biomarkers can be candidates for drug 
development. Therefore, HDL-C, which did not show causality, cannot be a candidate for 
drug development but can be used as an IHD predictor for finding high risk groups.24)
To our knowledge, this is the first study to examine the causality between lipid levels and IHD 
risk in a Korean population using 2-sample MR. In addition, all other previously published 
MR studies have been conducted primarily in populations of European descent. Thus, all 
instrument variables have been extracted from GWASs of European descent. In this study, we 
used a restricted set of SNPs for lipid levels within a Korean population (KoGES data) using 
individual-level data to avoid potential population substructure. We also verified the IHD 
events using the NHIS database. Koreans have good access to medical services as almost all 
citizens are enrolled in national health insurance.
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This study has several limitations. First, this study includes possible measurement errors: 
according to previous research,16) clinical data from the health promotion centers were 
one-time measurements of serum lipids and other variables. Cholesterol levels are likely to 
fluctuate over time, failure to consider these changes may have been a factor that obscures 
relevance. Second, due to using KCPS-II data, which is a non-community-based sample, any 
potential risk estimator cannot be validated. Third, selected lipid instruments may not be 
useful in other ethnic groups. Therefore, our study findings may not be generalized to other 
ethnicities. Fourth, this study did not examine all IHD events. The IHD events in this study 
were used only in the ‘non-fatal IHD events’ validated in hospital records, and therefore fatal 
coronary events cannot be explained. Finally, MR is a popular method for estimating causal 
effects of risk factors in observational studies, but it is difficult to completely exclude the 
effect of relevant unobserved potential confounders.
In conclusion, the study provides evidence that LDL-C and TG are causal biomarkers for the 
increased risk of developing IHD. Further studies that replicate this causal association among 
other ethnicities with larger samples and accurate outcome data are needed.
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